New index aims to help countries close breast cancer care gaps

A new tool may give governments a practical way to move from lofty global targets to on-the-ground action in the fight against breast cancer. Breast cancer has become the most common cancer worldwide, with around 2.3 million new cases and more than 666,000 deaths recorded in 2022, yet only a few countries are on track to meet the World Health Organization’s Global Breast Cancer Initiative goal of reducing mortality by 2.5% annually. “Across every region, women face systemic inequities that delay their diagnosis, limit their access to innovation, and compromise the quality of our care. These disparities are not incidental. They’re structural, and they reverberate through our families, our communities, and our economies,” Toyin Saraki, founder and president of The Wellbeing Foundation Africa, said at the Concordia summit held on the sidelines of the 80th United Nations General Assembly. In response to these inequities, a new initiative — The Breast Cancer Care Quality Index or BCCQI — aims to help countries translate global goals into national action plans. The tool allows governments to assess their policies, pinpoint weak spots, and map out tailored road maps for improvement. It is designed to support efforts to meet WHO’s mortality-reduction targets. “When you have something that’s the biggest killer, you have to use that to bring not just awareness, [but] action and investment to the problem,” Saraki told Devex. Developed by an international team of clinicians, policymakers, and advocates, with AstraZeneca serving as a convener, the BCCQI draws on evidence reviews and extensive expert consultations to define four key dimensions — early detection, timely diagnosis, comprehensive management, and resilient health systems. These are further broken down into 10 targets and 23 measurable indicators. Saraki — who is also a member of the AstraZeneca Breast Cancer Care Council — said she was drawn to the index because it provides an opportunity to turn expert data into practical information that governments, policymakers, health practitioners, and even women themselves can easily understand and use. The goal is to help medical professionals and clinics establish clear patient-navigation pathways, ensure access to the latest treatments, and measure progress along the way. Saraki hopes early adopters will use the index to benchmark national data, identify gaps such as late-stage diagnoses or weak referral systems, and develop plans to strengthen cancer programs. The index developers are also working toward a multilateral U.N. resolution that will bring visibility to the index. But challenges remain. Many low- and middle-income countries still lack robust cancer registries and trained staff to collect and analyze data — critical prerequisites for using the index effectively. Sustained political will and dedicated funding will also be essential to translate the framework into improved survival rates. “When you have the political will, everything else will work. You will have the resources in place, you will have the commitment in the different levels of the bureaucracy and the different programs, but political will is key,” said former Costa Rican President Laura Chinchilla at the Concordia event. “Without leadership and sustained commitment, even the best of frameworks cannot deliver the change that women deserve,” Saraki added.